Company Filing History:
Years Active: 2022
Title: Innovations in Therapeutic Proteins by Daniela Keilberg
Introduction
Daniela Keilberg is an accomplished inventor based in San Bruno, CA (US). She has made significant contributions to the field of therapeutic proteins, particularly in the treatment of epithelial barrier function disorders. Her work is vital for addressing various human diseases, especially those related to gastrointestinal health.
Latest Patents
Keilberg holds a patent for "Proteins for the treatment of epithelial barrier function disorders." This patent discloses therapeutic proteins and pharmaceutical compositions that are useful in treating human gastrointestinal inflammatory diseases. The therapeutic proteins are particularly effective for conditions associated with decreased epithelial cell barrier function or integrity. This includes inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
Career Highlights
Keilberg is currently associated with Second Genome, Inc., where she continues to innovate in the field of biotechnology. Her research focuses on developing solutions that enhance the treatment of gastrointestinal conditions, thereby improving patient outcomes.
Collaborations
Some of her notable coworkers include Cristina N Butterfield and Andrew Whitman Goodyear. Their collaborative efforts contribute to the advancement of therapeutic strategies in the biotechnology sector.
Conclusion
Daniela Keilberg's work in therapeutic proteins represents a significant advancement in the treatment of gastrointestinal diseases. Her innovative approach and dedication to research continue to pave the way for new therapeutic options.